Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06148272 · ClinicalTrials.gov registry record · Phase 1

A Study of LY3971297 in Healthy Participants

A Phase 1 study of Healthy and Obesity, sponsored by Eli Lilly and Company.

Recruiting
Registry status
Phase 1
Development phase
225
Enrollment target
7
Study locations

NCT06148272 is a Phase 1 study of Healthy and Obesity that is actively recruiting participants, run by Eli Lilly and Company. The registered enrollment target is 225 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (65% lower). The trial reports 7 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06148272, a Phase 1 study of Healthy and Obesity, is actively recruiting participants, sponsored by Eli Lilly and Company.

RECRUITING
Registry status
Phase 1
Development phase
225 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to measure side effects of LY3971297 injection administered under the skin in healthy participants and obese participants with high blood pressure (BP). Blood tests will be performed to check how much LY3971297 gets into the bloodstream and how long it takes the body to eliminate it. This is a 7-part study. The study duration will be approximately 60 days for Parts A and F, and approximately 90 days for Parts B, C, D, E, and G.

Conditions Studied

Healthy Obesity Hypertension

Interventions

  • DRUG Placebo
  • DRUG LY3971297
  • DRUG LY3971297 IV

Study Locations (7)

Other

  • Hakata Clinic - Fukuoka
  • P-One Clinic - Hachiōji
  • Clinical Research Hospital Tokyo - Shinjuku-ku
  • Lilly Centre for Clinical Pharmacology - Singapore

California

  • CenExel ACT - Anaheim

Florida

  • Clinical Pharmacology of Miami - Miami

Texas

  • ICON Early Phase Services - San Antonio

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2023-12-07
Est. Completion 2026-09
Phase Phase 1

Sponsor

Eli Lilly and Company

1,341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06148272

The ClinicalTrials.gov registry entry for NCT06148272 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (65% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06148272 reports 7 study locations spanning 4 distinct geographic areas - top geographies include Other, California, Florida.

Frequently Asked Questions

What is clinical trial NCT06148272 about?

NCT06148272 is a clinical study titled "A Study of LY3971297 in Healthy Participants". The purpose of this study is to measure side effects of LY3971297 injection administered under the skin in healthy participants and obese participants with high blood pressure (BP). Blood tests will be performed to check how much LY3971297 gets into the bloodstream and how long it takes the body to ...

What is the current status of trial NCT06148272?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 225 participants. The study started on 2023-12-07. Estimated completion is 2026-09.

What conditions does trial NCT06148272 study?

This clinical trial studies the following conditions: Healthy, Obesity, Hypertension.

What interventions are being tested in trial NCT06148272?

The interventions under investigation include: Placebo (DRUG), LY3971297 (DRUG), LY3971297 IV (DRUG).

Who is sponsoring clinical trial NCT06148272?

This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06148272 being conducted?

This trial has 7 study locations across California, Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Obesity

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.